Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zydus Therapeutics Inc.

Clinical trials sponsored by Zydus Therapeutics Inc., explained in plain language.

Now part of Zydus Lifesciences Limited ZYDUSLIFE NSE

US subsidiary of Zydus Lifesciences, developing pharmaceutical products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2 Terminated 2

New hope for PBC patients: phase 3 trial of saroglitazar launches

Disease control Not yet recruiting

This study tests a new drug, saroglitazar magnesium, in 89 adults with primary biliary cholangitis (PBC) who did not get enough benefit from or could not tolerate standard treatment (UDCA). The goal is to see if the drug can lower a key liver enzyme (alkaline phosphatase) to norm…

Phase: PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC